The sub-Saharan Africa position statement on the redefinition of fatty liver disease: from NAFLD to MAFLD.

[1]  Mai Mehrez,et al.  The NAFLD‐MAFLD debate: Eminence vs evidence , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[2]  M. Silva,et al.  The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease. , 2020, The lancet. Gastroenterology & hepatology.

[3]  G. Shiha,et al.  Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. , 2020, The lancet. Gastroenterology & hepatology.

[4]  A. Kengne,et al.  How well are non-communicable disease services being integrated into primary health care in Africa: A review of progress against World Health Organization’s African regional targets , 2020, PloS one.

[5]  J. Dufour,et al.  Redefining fatty liver disease: an international patient perspective. , 2020, The lancet. Gastroenterology & hepatology.

[6]  V. Wong,et al.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease , 2020, Hepatology International.

[7]  S. Bollipo,et al.  What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’ , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[8]  V. Wong,et al.  A new definition for metabolic associated fatty liver disease: an international expert consensus statement. , 2020, Journal of hepatology.

[9]  A. Sié,et al.  Epidemiology of multimorbidity in conditions of extreme poverty: a population-based study of older adults in rural Burkina Faso , 2020, BMJ Global Health.

[10]  A. Sanyal,et al.  MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. , 2020, Gastroenterology.

[11]  Dan J Stein,et al.  Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017. , 2019, The Lancet. Global health.

[12]  S. Vento,et al.  Liver cirrhosis in sub-Saharan Africa: neglected, yet important. , 2018, The Lancet. Global health.

[13]  N. Sattar,et al.  Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease , 2018, BMC Medicine.

[14]  C. Mathers,et al.  Acting on non-communicable diseases in low- and middle-income tropical countries , 2018, Nature.

[15]  L. Henry,et al.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018, Nature Reviews Gastroenterology & Hepatology.

[16]  K. Narayan,et al.  Global noncommunicable diseases--lessons from the HIV-AIDS experience. , 2011, The New England journal of medicine.

[17]  B. Lambdin,et al.  Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique - a case study , 2010, Journal of the International AIDS Society.

[18]  Y. Kinfu,et al.  The health worker shortage in Africa: are enough physicians and nurses being trained? , 2009, Bulletin of the World Health Organization.